Huntington National Bank Cytokinetics Inc Transaction History
Huntington National Bank
- $13.8 Billion
- Q4 2024
A detailed history of Huntington National Bank transactions in Cytokinetics Inc stock. As of the latest transaction made, Huntington National Bank holds 116 shares of CYTK stock, worth $5,010. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116
Previous 150
22.67%
Holding current value
$5,010
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$634 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$515 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$464 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$266 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$123 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.07B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...